Litcius/Paper detail

Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients

Qi Yu, Yu Xia, Zhiyuan Lin, Yang Qu, Yangyang Qi, Yifan Chen, Quan Zhou, Han Zeng, Jiajun Wang, Yuan Chang, Qi Bai, Yiwei Wang, Yu Zhu, Le Xu, Lingli Chen, Yunyi Kong, Weijuan Zhang, Bo Dai, Li Liu, Jianming Guo, Jiejie Xu

2020Cancer Immunology Immunotherapy119 citationsDOIOpen Access PDF

Topics & Concepts

CD8Immune systemClear cell renal cell carcinomaTumor-infiltrating lymphocytesMedicineTumor microenvironmentImmunotherapyT cellCytotoxic T cellCancer researchFlow cytometryInternal medicineRenal cell carcinomaImmunologyBiologyIn vitroBiochemistryCancer Immunotherapy and BiomarkersCAR-T cell therapy researchRenal cell carcinoma treatment
Tumor-infiltrating CD39+CD8+ T cells determine poor prognosis and immune evasion in clear cell renal cell carcinoma patients | Litcius